Press release
Epilepsy Market Information Related To Pipeline Products, News and Deals is Available In The Report
About Epilepsy Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H1 2018, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581020
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods of unconsciousness or convulsions. Symptoms of epilepsy are repeated seizures, weakness, and anxiety, loss of consciousness and contraction, or jerking, of body muscles. Main causes of epilepsy include low oxygen during birth, head injuries that occur during birth or from accidents during youth or adulthood, brain tumors, genetic conditions that result in brain injury, such as tuberous sclerosis, infections such as meningitis or encephalitis, and stroke or any other type of damage to the brain.
Request for TOC @ https://www.marketresearchreports.biz/reports/1581020/epilepsy-pipeline-review-h1-2018-market-research-reports/toc
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Epilepsy - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 7, 12, 15, 24, 1, 3, 69, 12 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 18 and 2 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
View Report @ https://www.marketresearchreports.biz/reports/1581020/epilepsy-pipeline-review-h1-2018-market-research-reports
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Epilepsy (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Epilepsy (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Epilepsy (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Epilepsy (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Epilepsy (Central Nervous System)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Epilepsy (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Epilepsy (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
Introduction 6
Epilepsy - Overview 7
Epilepsy - Therapeutics Development 8
Epilepsy - Therapeutics Assessment 30
Epilepsy - Companies Involved in Therapeutics Development 44
Epilepsy - Drug Profiles 77
Epilepsy - Dormant Projects 379
Epilepsy - Discontinued Products 388
Epilepsy - Product Development Milestones 390
Appendix 401
List of Tables
Number of Products under Development for Epilepsy, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Epilepsy - Pipeline by Abide Therapeutics Inc, H1 2018
Epilepsy - Pipeline by Adamas Pharmaceuticals Inc, H1 2018
Epilepsy - Pipeline by Advicenne SA, H1 2018
Epilepsy - Pipeline by Aequus Pharmaceuticals Inc, H1 2018
Epilepsy - Pipeline by Affectis Pharmaceuticals AG, H1 2018
Epilepsy - Pipeline by Anavex Life Sciences Corp, H1 2018
Epilepsy - Pipeline by Aphios Corp, H1 2018
Epilepsy - Pipeline by Aquestive Therapeutics, H1 2018
Epilepsy - Pipeline by Aucta Pharmaceuticals LLC, H1 2018
Epilepsy - Pipeline by Bial - Portela & Ca SA, H1 2018
Epilepsy - Pipeline by BioCrea GmbH, H1 2018
Epilepsy - Pipeline by Biogen Inc, H1 2018
Epilepsy - Pipeline by BioHealthonomics Inc, H1 2018
Epilepsy - Pipeline by Bionomics Ltd, H1 2018
Epilepsy - Pipeline by Biovista Inc, H1 2018
Epilepsy - Pipeline by Biscayne Pharmaceuticals Inc, H1 2018
Epilepsy - Pipeline by Catalyst Pharmaceuticals Inc, H1 2018
Epilepsy - Pipeline by Cavion LLC, H1 2018
Epilepsy - Pipeline by Cerecor Inc, H1 2018
Epilepsy - Pipeline by Crossject SA, H1 2018
Epilepsy - Pipeline by Eisai Co Ltd, H1 2018
Epilepsy - Pipeline by Gilead Sciences Inc, H1 2018
Epilepsy - Pipeline by Glialogix Inc, H1 2018
Epilepsy - Pipeline by Grifols SA, H1 2018
Epilepsy - Pipeline by GW Pharmaceuticals Plc, H1 2018
Epilepsy - Pipeline by Idorsia Ltd, H1 2018
Epilepsy - Pipeline by Insys Therapeutics Inc, H1 2018
Epilepsy - Pipeline by Iproteos SL, H1 2018
Epilepsy - Pipeline by Johnson & Johnson, H1 2018
Epilepsy - Pipeline by Knopp Biosciences LLC, H1 2018
Epilepsy - Pipeline by Lead Discovery Center GmbH, H1 2018
Epilepsy - Pipeline by Lotus Pharmaceutical Co Ltd, H1 2018
Epilepsy - Pipeline by Marinus Pharmaceuticals Inc, H1 2018
Epilepsy - Pipeline by Medicure Inc, H1 2018
Epilepsy - Pipeline by Medlab Clinical Ltd, H1 2018
Epilepsy - Pipeline by Mitochon Pharmaceuticals Inc, H1 2018
Epilepsy - Pipeline by MMJ PhytoTech Ltd, H1 2018
Epilepsy - Pipeline by Neurelis Inc, H1 2018
Epilepsy - Pipeline by Neurocrine Biosciences Inc, H1 2018
Epilepsy - Pipeline by NeuroCycle Therapeutics GmbH, H1 2018
Epilepsy - Pipeline by Neuron Biopharma SA, H1 2018
Epilepsy - Pipeline by NoNO Inc, H1 2018
Epilepsy - Pipeline by Novartis AG, H1 2018
Epilepsy - Pipeline by OPKO Health Inc, H1 2018
Epilepsy - Pipeline by Ovid Therapeutics Inc, H1 2018
Epilepsy - Pipeline by Pfizer Inc, H1 2018
Epilepsy - Pipeline by Promius Pharma LLC, H1 2018
Epilepsy - Pipeline by PTC Therapeutics Inc, H1 2018
Epilepsy - Pipeline by reMYND NV, H1 2018
Epilepsy - Pipeline by Sage Therapeutics Inc, H1 2018
Epilepsy - Pipeline by Saniona AB, H1 2018
Epilepsy - Pipeline by SciFluor Life Sciences LLC, H1 2018
Epilepsy - Pipeline by Serina Therapeutics Inc, H1 2018
Epilepsy - Pipeline by Shire Plc, H1 2018
Epilepsy - Pipeline by SK Biopharmaceuticals Co Ltd, H1 2018
Epilepsy - Pipeline by Suda Ltd, H1 2018
Epilepsy - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2018
Epilepsy - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2018
Epilepsy - Pipeline by Taro Pharmaceutical Industries Ltd, H1 2018
Epilepsy - Pipeline by The Cell-Factory BVBA, H1 2018
Epilepsy - Pipeline by Trillium Therapeutics Inc, H1 2018
Epilepsy - Pipeline by Turing Pharmaceuticals AG, H1 2018
Epilepsy - Pipeline by UCB SA, H1 2018
Epilepsy - Pipeline by Ultragenyx Pharmaceutical Inc, H1 2018
Epilepsy - Pipeline by Upsher-Smith Laboratories Inc, H1 2018
Buy Now @ https://www.researchmoz.com/checkout?rep_id=1581020&licType=S
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy Market Information Related To Pipeline Products, News and Deals is Available In The Report here
News-ID: 955765 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Epilepsy
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global…
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Epilepsy Market are:
• Idexx Laboratories Inc.
• PBD Biotech Ltd
• Thermo Fisher Scientific Inc.
• Innovative Diagnostics SAS
• Neogen Corp
• Enfer Labs
• bioMerieux SA
• Ring Biotechnology Co Ltd
• Bionote Inc.
• Shenzhen Bioeasy Biotechnology Co Ltd.
Contact Us:
If you have any queries about this report or if…
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aims…
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 …
The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/A14821
Epilepsy devices play…
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei …
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029
This…
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy …
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curve…
